Improvement of glucose tolerance by bezafibrate in non-obese patients with hyperlipidemia and impaired glucose tolerance
- 1 October 1994
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 25 (3) , 199-205
- https://doi.org/10.1016/0168-8227(94)90009-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Hyperinsulinemia in patients with hypercholesterolemiaJournal of Clinical Endocrinology & Metabolism, 1992
- Bezafibrate Retard in Type II Diabetic PatientsJournal of Cardiovascular Pharmacology, 1990
- Effect of Bezafibrate on Metabolic Profiles in Non-Insulin-Dependent Diabetes MellitusJournal of Cardiovascular Pharmacology, 1990
- Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDMDiabetes, 1989
- Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetesAtherosclerosis, 1989
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987
- THE SHORT‐ AND LONG‐TERM EFFECTS OF BEZAFIBRATE IN THE RAT*Annals of the New York Academy of Sciences, 1982
- TRIGLYCERIDE LOWERING EFFECT AND INDUCTION OF LIVER ENZYMES IN MALE RATS AFTER ADMINISTRATION OF HYPOLIPIDEMIC DRUGSAnnals of the New York Academy of Sciences, 1982
- Resistance to insulin but not to glucagon in lean human hypertriglyceridemicsDiabetes, 1980
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUSPublished by Elsevier ,1963